Remdesivir Didn't Cut Hospital Stay Or Mortality In Covid Patients: WHO

Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.

from NDTV News - Special https://ift.tt/3nX8fwP

Comments

Popular posts from this blog

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

Asteroid Discovery Suggests Ingredients for Life on Earth Came From Space

Smith's Horrible DRS Call Has Kohli In Splits. 'Worst Review' Says Twitter